Blue Horseshoe Stocks: CLTX Recap & More

Celsus Therapeutics Plc. CLTX

The big winner from yesterday’s report turned out to be CLTX. We tagged the stock after catching it on a routine news scan; the company announced an all-stock exchange agreement with Volution Immuno Pharmaceuticals in which CLTX will absorb the company as a wholly-owned subsidiary, and form a new company aimed at developing treatments for a range of rare and orphan autoimmune and inflammatory diseases >> READ PR

Back in February, a bleak annual report led CLTX to fall off of a cliff, tumbling from the $6+ range down to roughly a dollar. Over the next several months, the stock continued to trend downward, culminating in a 52-week low of .40 at the end of May. Since that time, it received a little boost, rising to the .60-range.

That’s where we came upon it yesterday, and it was fortunate that we began paying attention when we did. After dipping to a daily low of .5012, the stock ran into the close, reaching a high of .68; a solid 36% intraday move. The late boost of momentum is carrying over into the premarket today, with CLTX hitting an early high of .99. From our observed low yesterday, that’s a 98% swing.

We’ll look for it to continue to build its base with higher lows, and to potentially crack through resistance into dollar-territory.


Callaway Golf Co. ELY

ELY is contributing to the newsreel this morning, announcing the signing of a highly talented young golfer. Upon taking notice of this, we’ve also seen that ELY has been building a heck of a chart setup over the past few sessions.

The stock has registered higher lows for each of the last four consecutive trading sessions, and is exhibiting a great deal of promise with regard to a number of bullish signals on the chart that we’ve pointed out on the snapshot below. Between that, and it being the peak of golf season, we’ll be paying close attention to ELY.

CARLSBAD, Calif., July 14, 2015 /PRNewswire/ — Today Callaway Golf officially announced that it has reached a Staff Pro agreement with former college golf phenom, Julien Brun. A native of Anitbes, France, Brun turns pro after an unbelievable career at Texas Christian University (TCU), where he was a 3-time First Team All-American and a 3-time Academic All-American.>> FULL PR


EnteroMedics, Inc.  ETRM

Speaking of ripening charts, we’ve got to tag ETRM this morning as a bottom-play that could be in line for a serious rebound. One look at the chart is all it takes to see what we mean.

We’ve got an egregiously oversold RSI, and the stock has fallen to new 52-week lows in the past couple of sessions.  There are also a couple of gaps to fill from 44-.50 and from .83-.96 on a possible retrace, so we’ll be monitoring this play which we feel has breakout potential based on these factors.


Extended Watchlist:
BIOC, CLSN, TBIO, CEL, VLTC, CPXX

Blue Horseshoe Stocks: SPHS, OPXA, PPCH Highlights

Sophiris Bio, Inc. SPHS

SPHS was the first mention from yesterday’s morning report to grab our attention with an early surge that provided the chance at a rapid, substantial gain. From the low-of-day at 1.02, the stock made a big move to 1.64; an increase of 60% inside of the first half-hour of the session. The bulk of the day’s volume, which came in at more than 18X the three-month average, traded in that short time-span as well.

In addition to the heavy volume, making its biggest moves early in the trading day seems to be an established pattern with SPHS, so we’ll have an eye peeled as the session commences today.


Opexa Therapeutics, Inc. OPXA

The other standout from yesterday’s report was OPXA, which spiked on word of coverage initiation by large investment banking and research firm, Maxim Group. (>>View PR)

From its daily low of .43, the stock stair-stepped its way up throughout the session and eventually hit a high of .54; an intraday gain of 26% As it appears to gapping up in the premarket and has already touched .58, the total increase we’ve seen gets pushed to 35% We’ll be interested to follow the impending activity as well as check out the CEO’s presentation which we detail below.

Per a news release from last week, “Neil K. Warma, President and Chief Executive Officer, will present at the 2015 Marcum Microcap Conference on Thursday, May 28, 2015, at 11:30 a.m. EDT in the Plymouth Room. The conference will be held at the Grand Hyatt New York Hotel in New York, NY. A live webcast of the company presentation can be accessed here, or via the Investor Relations section of the Company’s website at www.opexatherapeutics.com.


Propanc Health Group Corp. PPCH

PPCH is a stock that we began tracking in the second week of March, and over the period of several weeks since that time the stock has made some truly epic moves. Subsequent to our tag of PPCH on March 18th, we observed a low of .0116, followed by an impressive run up to an even dime. That 762% mega-run was followed by a tapering back to a low of .021.

Yesterday the stock soared almost all the way back to its previous high, touching .094, which marks another swing of 348% that we;ve seen from this incredible mover. If the stock can breach that previous swing-high, it’ll be off to the races, so we’ll definitely keep PPCH an item of interest moving forward.


Extended Watchlist:
BIOC, NETE, OHGI, MNGA

Blue Horseshoe Stocks: Recap of Friday & Much More

Friday’s Options Ideas:

We had our eyes on a handful of options trading possibilities on Friday, and we did see some significant moves to the upside emerge from that group. We’ll kick things off this week by outlining some of the opportunities that were available for traders within the price ranges we specified in Friday’s report:

Skyworks Solutions, Inc. SWKS
$94.50 Calls – Range: 1.26-3.63 – Max Gain: 188%
$95 Calls – Range: .84-3.20 – Max Gain: 280%
$95.50 Calls – Range: .60-2.28 – Max Gain: 280%
$96 Calls – Range: .53-2.36 – Max Gain: 345%

Expedia, Inc. EXPE
$99 Calls – Range: 1.43-3.60 –  Max Gain: 152%
$99.50 Calls – Range: 2.00-2.83 – Max Gain: 41%

FireEye, Inc. FEYE
05/08 $42 Calls – Range: 1.70-2.55 – Max Gain: 50%
05/08 $43 Calls – Range: 1.25-2.00 – Max Gain: 60%

It’s quite the task for anyone to provide just one worthwhile options-trading idea, and on Friday, we were three for three. It serves as a great example of why we like to mix plenty of these options ideas into our daily reports; the gains are out there, ripe for the taking! 


Advanced Medical Isotope Corp. ADMD

Our attention was drawn to ADMD this morning as it popped up on our news scanner; the company has come forth with information regarding an “error in the calculation of common shares that should have properly been issued, resulting in significant excess issuances of common stock”. It essentially boils down to an estimated positive impact of $0.8M on ADMD’s balance sheet.

We naturally took a look at the ADMD chart upon taking notice of this news, and as we point out with the annotations below, there are several indications of a bullish trend in effect. As a result, we’ll want to keep watch over ADMD as we begin this new trading week.


Rebound For Social Media Stocks?

LinkedIn Corp. LNKD and Twitter, Inc. TWTR were both crushed on disappointing earnings last week, and both stocks appear to be gearing up for a possible recovery this week. They’re both slightly in the green here in the premarket this morning, and we’ll be looking for potential swing trade opportunities that might present themselves in coming weeks with Calls bearing a 05/29 expiration date.

On LinkedIn Corp. LNKD we’ll be monitoring the 05/29 $200-210 Call range. The longer period before expiration gives the stock some time to sustain a comeback off of recent lows.

For Twitter, Inc. TWTR we’ll actively monitor the 05/29 $38-42 Call range for similar opportunities.


Extended Watchlist:
PBR, ICLD, ARRY, BIOC, CYNI, SCOK, IBIO, XGTI, NRTI(Potential Bottom-Play)